New treatment for enlarged prostate with reduced risk
A latest technology will allow men who suffer with enlarged prostate to treat the condition with reduced risks of serious complications, the National Institute...
Martin Cowie stands down from NICE board, joins AstraZeneca
Professor Martin Cowie has resigned as non-executive director of the National Institute for Health and Care Excellence (NICE) to join pharma giant AstraZeneca.
He was...
‘MPharm students in UK won’t be required to pay additional fees for their foundation training year’
The General Pharmaceutical Council (GPhC) and Pharmaceutical Society of Northern Ireland (PSNI) have released an update on the planned reforms to the initial education...
Pharmacy school professor shortlisted for a Times Higher Education award
A professor of pharmaceutical engineering at Bradford university has made it to the shortlists for the 2020 Times Higher Education Awards – the “Oscars of higher...
England brings in more local restrictions as Covid-19 infection jump by 60 per cent in a week
The spread of the coronavirus is accelerating across all parts of England with one study suggesting cases were doubling each week, fuelling concerns further public restrictions...
GPhC takes action against six pharmacies for selling ‘high-risk medicines’
The General Pharmaceutical Council has taken robust enforcement action against six separate pharmacies after they were found to be selling "unusually high volumes" of...
Futuristic Advances in Diagnostics We Have Today
Technology advancements come along with medical advances. As decades pass by, people become smarter and wiser. Wherein they can invent and plan unimaginable diagnostics...
British company launches 20-second virus test
British start-up company iAbra said it had developed a 20-second saliva Covid-19 test which had 99.8 per cent sensitivity and 96.7 per cent specificity.
Trials of the "Virolens"...
Pharmacy bodies welcome EY report, renew calls for urgent funding to avert imminent closures
National pharmacy bodies have welcomed the findings of a report by accountancy firm EY and urged the government for a quick policy intervention and...
MHRA issues medicines defect notice for zopiclone tablets
The Medicines and Health products Regulatory Agency (MHRA) has issued a class four medicines defect notice for zopiclone tablets.
The defect information notice issued for...
Current Issue March 2024
